Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2

BACKGROUND: Seroepidemiology is an important tool to characterize the epidemiology and immunobiology of SARS-CoV-2 but many immunoassays have not been externally validated raising questions about reliability of study findings. To ensure meaningful data, particularly in a low seroprevalence populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilles, Eric J., Karlson, Elizabeth W., Norman, Maia, Gilboa, Tal, Fischinger, Stephanie, Atyeo, Caroline, Zhou, Guohai, Bennett, Christopher L., Tolan, Nicole V., Oganezova, Karina, Walt, David R., Alter, Galit, Simmons, Daimon P., Schur, Peter, Jarolim, Petr, Baden, Lindsey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325183/
https://www.ncbi.nlm.nih.gov/pubmed/32607518
http://dx.doi.org/10.1101/2020.06.24.20139006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325183/
https://www.ncbi.nlm.nih.gov/pubmed/32607518
http://dx.doi.org/10.1101/2020.06.24.20139006

Ejemplares similares